Last reviewed · How we verify
B-MPH
At a glance
| Generic name | B-MPH |
|---|---|
| Also known as | Ritalin LA |
| Sponsor | New York State Psychiatric Institute |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Trial to Assess How Centanafadine Interacts With Stimulants in the Body (PHASE1)
- Methylphenidate in Childhood Apraxia of Speech (PHASE2)
- Treadmill Training With and Without Compression Stockings on Toe Walking and Balance in Children With Autism. (NA)
- EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders (PHASE3)
- Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI (PHASE1)
- Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD (PHASE1,PHASE2)
- Effect of Alter-G Training on Glycemic Control and Quality of Life in Diabetic Neuropathy (NA)
- The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |